Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -21.468% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc(N2CC(C(=O)NCc3cccnc3)CC2=O)ccc1C(C)C
b: O=C(Nc1ccnn1C1CCN(C2CCCCC2)CC1)c1ccccc1
Answer: a. Cc1cc(N2CC(C(=O)NCc3cccnc3)CC2=O)ccc1C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(N2CC(C(=O)NCc3cccnc3)CC2=O)ccc1C(C)C
Cc1cc(N2CC(C(=O)NCc3cccnc3)CC2=O)ccc1C(C)C
1-(3-methyl-4-propan-2-ylphenyl)-5-oxo-N-(pyridin-3-ylmethyl)pyrrolidine-3-carboxamide